Last reviewed · How we verify
Administering remimazolam
At a glance
| Generic name | Administering remimazolam |
|---|---|
| Sponsor | Iuliu Hatieganu University of Medicine and Pharmacy |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Actualities in Procedural Sedation: Remimazolam (PHASE4)
- A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy (PHASE4)
- Use of Remimazolam and Fentanyl for Procedural Sedation in Patients Undergoing Dental Extraction (PHASE4)
- A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients (PHASE2, PHASE3)
- Remimazolam Consumption: TCI vs. Manual Infusion (NA)
- Dexmedetomidine Nasal Spray and Pediatric Bronchoscopy (NA)
- A Randomized, Controlled Clinical Trial Comparing Remimazolam Besylate Combined With Alfentanil Versus Propofol Combined With Alfentanil for Anesthesia in Thoracic Surgery (PHASE4)
- A Non-intervention Fiberoptic Bronchoscopy Study of Remazolam Toluene Sulfonate for Injection Under General Anesthesia and Fiberoptic Bronchoscopy
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: